Sensorion (ALSEN) Reports H1 2026 Results; Cash €88M, Funds Into 2027
Sensorion reported H1 2026 results: cash and short-term deposits €88M, net loss €20.7M. Company says funding runway extends to end-2027 and ANSM authorized the Phase I/II HearConnex trial for SENS-601 in France; first dosing expected by early 2027.Material DetailsContext by AI AnalystEarly-stage bi…